ArticleInternational journal of obesity (2005)2026
Indirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes.
Andreea Ciudin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.